Moore Capital Management LP Invests $590,000 in Avanos Medical, Inc. (NYSE:AVNS)

Moore Capital Management LP purchased a new position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 37,070 shares of the company's stock, valued at approximately $590,000. Moore Capital Management LP owned approximately 0.08% of Avanos Medical as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Quantbot Technologies LP bought a new stake in shares of Avanos Medical during the 4th quarter worth about $64,000. Tower Research Capital LLC TRC lifted its position in shares of Avanos Medical by 493.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock worth $129,000 after purchasing an additional 6,714 shares during the last quarter. EP Wealth Advisors LLC lifted its position in shares of Avanos Medical by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after purchasing an additional 1,289 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Avanos Medical during the 4th quarter worth about $162,000. Finally, Mariner LLC lifted its position in shares of Avanos Medical by 18.0% during the 4th quarter. Mariner LLC now owns 10,655 shares of the company's stock worth $170,000 after purchasing an additional 1,625 shares during the last quarter. Institutional investors own 95.17% of the company's stock.

Avanos Medical Stock Performance

Shares of NYSE AVNS traded up $0.37 during trading hours on Friday, hitting $13.12. 582,928 shares of the company's stock were exchanged, compared to its average volume of 355,149. Avanos Medical, Inc. has a 1-year low of $11.84 and a 1-year high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The stock has a market capitalization of $606.54 million, a price-to-earnings ratio of 38.58 and a beta of 1.13. The company's 50-day moving average price is $13.19 and its 200-day moving average price is $15.74.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The business had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. During the same quarter in the previous year, the firm earned $0.22 EPS. The firm's revenue was up .8% compared to the same quarter last year. On average, sell-side analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Insider Buying and Selling at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now owns 82,047 shares of the company's stock, valued at $1,251,216.75. This represents a 7.86% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 2.64% of the company's stock.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.